普生 4117.TW Value Analysis
TW StockBiotech. & Medical
(No presentation for 4117)
4117 Value Score
3
24
15
Limited Growth
- AI analysis rates 4117 with a lower value score of 2.
- It is mainly due to unstable operating cash flow, along with lower ROE.
- Over the past 3 months, 4117 has maintained a consecutive value rating of 2.0, higher than the rating of 4.1 over the past 3 years, indicating noticeable decrease in enterprise value.
- Compared to all stocks in the Biotech. & Medical sector, 4117 has a medium value rating.
4117 Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
Update to 2025/04/25 (Weekly Update)
4117 Financial Forecast
Unit : TWD
Update to 2025/5/9 (Quarterly Update)
4117 Earnings Table
No related data records
4117 Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
4117 Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of 4117 from 2007/01 till Now
- -54.76%
- Cumulative Return
- -4.34%
- Annual Return
- 39.42%
- Volatility
- -0.11
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from January, 2007 to May, 2025. (Total Trades: 2)
| 4117 | Sector | TW Overall Market | |
|---|---|---|---|
| Wining Rate | - | 46% | 53% |
| Avg Return | -37.8% | 21.1% | 45.4% |
| Avg Profit | - | 72.2% | 102.9% |
| Avg Loss | -37.8% | -22.4% | -20.3% |
| Avg Risk-Reward Ratio | - | 322.8% | 505.8% |
Update to 2025/5/10 (Daily Update)